Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Down-regulation of the epithelial Na⁺ channel ENaC by Janus kinase 2.
Hosseinzadeh Z, Luo D, Sopjani M, Bhavsar SK, Lang F.
???displayArticle.abstract???
Janus kinase-2 (JAK2), a signaling molecule mediating effects of various hormones including leptin and growth hormone, has previously been shown to modify the activity of several channels and carriers. Leptin is known to inhibit and growth hormone to stimulate epithelial Na(+) transport, effects at least partially involving regulation of the epithelial Na(+) channel ENaC. However, no published evidence is available regarding an influence of JAK2 on the activity of the epithelial Na(+) channel ENaC. In order to test whether JAK2 participates in the regulation of ENaC, cRNA encoding ENaC was injected into Xenopus oocytes with or without additional injection of cRNA encoding wild type JAK2, gain-of-function (V617F)JAK2 or inactive (K882E)JAK2. Moreover, ENaC was expressed with or without the ENaC regulating ubiquitin ligase Nedd4-2 with or without JAK2, (V617F)JAK2 or (K882E)JAK2. ENaC was determined from amiloride (50 μM)-sensitive current (I(amil)) in dual electrode voltage clamp. Moreover, I(amil) was determined in colonic tissue utilizing Ussing chambers. As a result, the I(amil) in ENaC-expressing oocytes was significantly decreased following coexpression of JAK2 or (V617F)JAK2, but not by coexpression of (K882E)JAK2. Coexpression of JAK2 and Nedd4-2 decreased I(amil) in ENaC-expressing oocytes to a larger extent than coexpression of Nedd4-2 alone. Exposure of ENaC- and JAK2-expressing oocytes to JAK2 inhibitor AG490 (40 μM) significantly increased I(amil). In colonic epithelium, I(amil) was significantly enhanced by AG490 pretreatment (40 μM, 1 h). In conclusion, JAK2 is a powerful inhibitor of ENaC.
Alesutan,
Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2.
2012, Pubmed,
Xenbase
Alesutan,
Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2.
2012,
Pubmed
,
Xenbase Almilaji,
Down-regulation of Na/K+ atpase activity by human parvovirus B19 capsid protein VP1.
2013,
Pubmed
,
Xenbase Almilaji,
Upregulation of Na+,Cl(-)-coupled betaine/γ-amino-butyric acid transporter BGT1 by Tau tubulin kinase 2.
2013,
Pubmed
,
Xenbase Baskin,
The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors.
2010,
Pubmed Bełtowski,
Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin.
2010,
Pubmed Bhavsar,
Energy-sensitive regulation of Na+/K+-ATPase by Janus kinase 2.
2014,
Pubmed
,
Xenbase Bhavsar,
Stimulation of the amino acid transporter SLC6A19 by JAK2.
2011,
Pubmed
,
Xenbase Böhmer,
The shrinkage-activated Na(+) conductance of rat hepatocytes and its possible correlation to rENaC.
2000,
Pubmed
,
Xenbase Brooks,
The growth hormone receptor: mechanism of activation and clinical implications.
2010,
Pubmed Coatmellec-Taglioni,
Factors that influence the risk of hypertension in obese individuals.
2003,
Pubmed Coaxum,
Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin.
2009,
Pubmed Deachapunya,
Site-specific regulation of ion transport by prolactin in rat colon epithelium.
2012,
Pubmed Dorkkam,
Prolactin stimulates the L-type calcium channel-mediated transepithelial calcium transport in the duodenum of male rats.
2013,
Pubmed Friedrich,
The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel alpha,beta,gamma-ENaC.
2003,
Pubmed
,
Xenbase Garnovskaya,
Hypertonicity activates Na+/H+ exchange through Janus kinase 2 and calmodulin.
2003,
Pubmed Gatsios,
Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock.
1998,
Pubmed Gong,
Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
1998,
Pubmed Han,
Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.
2006,
Pubmed Helms,
Role of SGK1 in nitric oxide inhibition of ENaC in Na+-transporting epithelia.
2005,
Pubmed
,
Xenbase Henrion,
Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel.
2012,
Pubmed
,
Xenbase Ho,
JAK2 Translocations in hematological malignancies: Review of the literature.
2010,
Pubmed Hosseinzadeh,
Downregulation of ClC-2 by JAK2.
2012,
Pubmed
,
Xenbase Hosseinzadeh,
Stimulation of the glucose carrier SGLT1 by JAK2.
2011,
Pubmed
,
Xenbase Hosseinzadeh,
Regulation of the glutamate transporters by JAK2.
2011,
Pubmed
,
Xenbase Hosseinzadeh,
Up-regulation of the betaine/GABA transporter BGT1 by JAK2.
2012,
Pubmed
,
Xenbase Hosseinzadeh,
Downregulation of KCNQ4 by Janus kinase 2.
2013,
Pubmed
,
Xenbase Kamenicky,
Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.
2008,
Pubmed Kamynina,
Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport.
2002,
Pubmed Kunzelmann,
Electrolyte transport in the mammalian colon: mechanisms and implications for disease.
2002,
Pubmed Kurdi,
JAK redux: a second look at the regulation and role of JAKs in the heart.
2009,
Pubmed Lang,
(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.
2006,
Pubmed Lopez,
Molecular basis of cytokine receptor activation.
2010,
Pubmed Mahfouz,
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon.
2011,
Pubmed Morris,
Recent advances in understanding leptin signaling and leptin resistance.
2009,
Pubmed Noon-Song,
Controlling nuclear JAKs and STATs for specific gene activation by IFNγ.
2011,
Pubmed Oh,
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.
2010,
Pubmed Pakladok,
PIKfyve sensitivity of hERG channels.
2013,
Pubmed
,
Xenbase Pardanani,
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.
2011,
Pubmed Park,
Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans.
2013,
Pubmed Pathare,
OSR1-sensitive renal tubular phosphate reabsorption.
2012,
Pubmed
,
Xenbase Qiu,
Leptin excites proopiomelanocortin neurons via activation of TRPC channels.
2010,
Pubmed Rexhepaj,
SGK1 is not required for regulation of colonic ENaC activity.
2006,
Pubmed Ross,
Amiloride-sensitive Na+ channels contribute to regulatory volume increases in human glioma cells.
2007,
Pubmed Rossier,
Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors.
2002,
Pubmed Santos,
JAK2 inhibitors: what's the true therapeutic potential?
2011,
Pubmed Schmid,
SGK3 regulates Ca(2+) entry and migration of dendritic cells.
2012,
Pubmed Selvaraj,
Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
2000,
Pubmed Shen,
JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene 1 expression.
2010,
Pubmed Snyder,
Down-regulating destruction: phosphorylation regulates the E3 ubiquitin ligase Nedd4-2.
2009,
Pubmed Spivak,
Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation.
2010,
Pubmed Tefferi,
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.
2010,
Pubmed Venkitachalam,
Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene.
2012,
Pubmed Villarreal,
Leptin blockade attenuates sodium excretion in saline-loaded normotensive rats.
2006,
Pubmed Villarreal,
Renal effects of leptin in normotensive, hypertensive, and obese rats.
1998,
Pubmed Wolf,
JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells.
2013,
Pubmed Xia,
Multiple regulatory sites in large-conductance calcium-activated potassium channels.
2002,
Pubmed Yang,
Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2.
2010,
Pubmed Yao,
Heme controls the regulation of protein tyrosine kinases Jak2 and Src.
2010,
Pubmed Yeh,
The Janus kinase family of protein tyrosine kinases and their role in signaling.
1999,
Pubmed Yokota,
Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action.
1998,
Pubmed
